Features

Arka Pharmaceutical is proud to unveil its latest innovation in the realm of healthcare: ARAKCEF TAZO injection. As a leading pharmaceutical company dedicated to advancing medical science and improving patient outcomes, we are committed to delivering cutting-edge solutions that address the most pressing healthcare challenges of our time.

ARAKCEF TAZO injection is a potent combination of two powerful antibiotics: Ceftriaxone and Tazobactam. This dynamic duo synergizes to combat a wide range of bacterial infections, offering a robust defense against even the most stubborn pathogens.

Ceftriaxone, a third-generation cephalosporin antibiotic, targets bacterial cell walls, disrupting their integrity and inhibiting their growth. Meanwhile, Tazobactam, a beta-lactamase inhibitor, shields Ceftriaxone from degradation by beta-lactamase enzymes produced by certain bacteria, thereby enhancing its efficacy.